0 Mesothelioma Research

Mesothelioma Research

Mesothelioma Research

Mesothelioma is a disease that is still very hard to recognise, difficult to diagnose and virtually impossible to treat effectively. It is known that the disease is asbestos related and that there is a long latency period before symptoms become apparent. But with more and more cases coming to light each year, it is vital that further research is carried out in order to make this fatal disease more manageable for both patients and doctors.

Many organizations are involved in research in to mesothelioma. This includes the companies that are responsible for the use of asbestos. Many people that have been diagnosed with mesothelioma have now discovered that they can claim compensation for being exposed to hazardous asbestos by companies, which means that these companies have a responsibility to help with this research.

The National Institute of Cancer is also working hard to research mesothelioma, its symptoms, diagnosis and treatment. The rising number of mesothelioma cases means that it is essential to learn more about this disease in order to look into developing treatments.

With many mesothelioma patients now seeking legal advice, it has become essential for law firms to learn about and research the disease. It is the lawyer’s job to assist the mesothelioma patient and provide advice and resources from which the patient can get help and assistance. Therefore, law firms dealing with these types of cases also have a responsibility to learn about the disease and what can be done to help patients.

A great deal of research into mesothelioma goes into learning about the effects of asbestos upon cells, and how the cells are changed by exposure to this material. By learning how healthy cells and corrupted by asbestos, we hope to learn more about how this cell corruption can be prevented or minimised.

The National Institute of Cancer has also carried out clinical trials into the treatment of mesothelioma. The trials, which are performed with real patients who have been diagnosed with mesothelioma, should help to determine how effective the various treatments are, and hopefully will go some way to helping experts find more effective treatments for the disease.

Mesothelioma trials are based upon treatments that are thought to have some value to patients. But the trials are just that – trials. This means that there are no guarantees and that a great deal more work and research will be required before a conclusive and effective treatment is found. On the upside, many new trials are being carried out on a regular basis, and with the information and technology available to scientists today, the discovery of an effective treatment for mesothelioma patients is just a matter of time.

Medical professionals worldwide are currently involved in clinical trials, and each trial depends upon the extent of spread of the disease. Some trials are performed on those who have been diagnosed reasonably early, others on patients who were not diagnosed until the latter stages of the disease. It is important for scientists to find a treatment that is effective not only on those who are diagnosed early, but on all patients that suffer from this killer disease.

The research carried out into mesothelioma will hopefully mean that future generations of suffers can be saved, even if they are diagnosed with the disease. The research carried out is extremely costly, and is often sponsored by associated companies such as drug companies and research groups as well as by the government. Research into the contraction of the disease, and its subsequent development will ultimately enable professionals to devise the most effective treatment.

Several new methods of treatment have been used following research into mesothelioma. These include:

Photodynamic therapy, which uses fixed frequency light to target abnormal cells and kill them off by the activation of photosensitizing drugs.

Immunotherapy, which fights the abnormal cells through the use of the body’s own defence system through enhancement and development of the immune system.

Intensity Modulated Radiation Therapy, which is a radiation treatment that targets just the affected area/tumour, thus avoiding contact with healthy cells and tissue.